Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome
NCT00004208
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
86
Enrollment
OTHER
Sponsor class
Conditions
Myelodysplastic Syndromes
Interventions
DRUG:
ATG + CSA
BEHAVIORAL:
Supportive care
Sponsor
Swiss Cancer Institute